References
Kuroyanagi Y, Gotoh Y, Kasahara K, Nagano C, Fujita N, Yamakawa S, Yamamoto M, Takeda A, Uemura O. Effectiveness and nephrotoxicity of a 2-year medium dose of cyclosporine in pediatric patients with steroid-dependent nephrotic syndrome: determination of the need for follow-up kidney biopsy. Clin Exp Nephrol. 2018;22(2):413–9.
Benz MR, Toenshoff B, Weber LT. Treatment of children with frequently relapsing steroid-sensitive nephrotic syndrome: recent trial results. Clin Investig. 2014;4(11):1043–54.
Iijima K, Sako M, Oba MS, Ito S, Hataya H, Tanaka R, Ohwada Y, Kamei K, Ishikura K, Yata N, Nozu K, Honda M, Nakamura H, Nagata M, Ohashi Y, Nakanishi K, Yoshikawa N. Cyclosporine C2 monitoring for the treatment of frequently relapsing nephrotic syndrome in children: a multicenter randomized phase II trial. Clin J Am Soc Nephrol. 2014;9(2):271–8.
Colombo MD, Perego R, Bellia G. Cyclosporine-associated nephrotoxicity. Open J Nephrol. 2013;3(03):168.
Kengne-Wafo S, Massella L, Diomedi-Camassei F, Gianviti A, Vivarelli M, Greco M, Stringini GR, Emma F. Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome. Clin J Am Soc Nephrol. 2009;4(9):1409–16.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declare no conflict of interests.
About this article
Cite this article
Abedini, A. Is medium dose of cyclosporine A effective in treatment of children with steroid-dependent nephrotic syndrome with reduction in corticosteroids dose consumption?. Clin Exp Nephrol 23, 287–288 (2019). https://doi.org/10.1007/s10157-018-1594-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-018-1594-y